{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T07:57:25Z","timestamp":1787990245622,"version":"build-2784847793"},"reference-count":237,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Advanced glycation end products (AGEs) are deleterious to tissues <jats:italic>in vivo<\/jats:italic>, arising from the process of non-enzymatic glycation (NEG), also referred to as the Maillard Reaction, which facilitates the non-enzymatic modification of biomolecules by saccharides. AGEs are integral to the physiological and pathophysiological processes associated with senescence, cardiovascular diseases (CVDs), neurodegenerative and neuroinflammatory diseases, diabetes mellitus (DM) and its complications, autoimmune and rheumatic inflammatory diseases, bone-degenerative diseases, and chronic renal diseases. Both endogenous AGEs and exogenous dietary AGEs can affect the structures and functions of proteins and lipids in cardiovascular tissues and the extracellular matrix of cardiovascular cells by inducing oxidative stress and inflammatory responses, causing direct cell and tissue dysfunction, and activating subsequent signaling pathways mediated by the AGE-RAGE axis. This review focuses on the roles and mechanisms of AGEs in CVDs, from cardiovascular tissues to concrete diseases like heart failure, valvular heart disease, and so on, together with the corresponding treatment and prevention strategies, aiming to provide a comprehensive overview of the roles of AGEs in CVDs and corresponding therapeutic measures.<\/jats:p>","DOI":"10.3389\/fcvm.2025.1637252","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T05:30:03Z","timestamp":1756704603000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["The roles of advanced glycation end products in cardiovascular diseases: from mechanisms to therapeutic strategies"],"prefix":"10.3389","volume":"12","author":[{"given":"Zhuo-Han","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Yao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1161\/CIR.0b013e31828124ad","article-title":"Heart disease and stroke statistics\u20132013 update: a report from the American Heart Association","volume":"127","author":"Go","year":"2013","journal-title":"Circulation"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1016\/s0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/eurjpc\/zwac285","article-title":"Global trends and regional differences in incidence and mortality of cardiovascular disease, 1990\u20132019: findings from 2019 global burden of disease study","volume":"30","author":"Li","year":"2023","journal-title":"Eur J Prev Cardiol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1093\/eurheartj\/ehq030","article-title":"Novel therapeutic concepts: the epidemic of cardiovascular disease in the developing world: global implications","volume":"31","author":"Gersh","year":"2010","journal-title":"Eur Heart J"},{"key":"B6","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s11892-019-1161-2","article-title":"Global updates on cardiovascular disease mortality trends and attribution of traditional risk factors","volume":"19","author":"Jagannathan","year":"2019","journal-title":"Curr Diab Rep"},{"key":"B7","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s12916-023-02925-4","article-title":"Global, regional, and national burden of cardiovascular diseases in youths and young adults aged 15\u201339 years in 204 countries\/territories, 1990\u20132019: a systematic analysis of global burden of disease study 2019","volume":"21","author":"Sun","year":"2023","journal-title":"BMC Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"888","DOI":"10.3390\/biom9120888","article-title":"Advanced glycation end products (AGEs) may be a striking link between modern diet and health","volume":"9","author":"Gill","year":"2019","journal-title":"Biomolecules"},{"key":"B9","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1076\/apab.104.7.797.13107","article-title":"Contributions to senescence: non-enzymatic glycosylation of proteins","volume":"104","author":"Sullivan","year":"1996","journal-title":"Arch Physiol Biochem"},{"key":"B10","doi-asserted-by":"publisher","first-page":"5591","DOI":"10.3390\/molecules25235591","article-title":"The development of Maillard reaction, and advanced glycation end product (AGE)-receptor for AGE (RAGE) signaling inhibitors as novel therapeutic strategies for patients with AGE-related diseases","volume":"25","author":"Shen","year":"2020","journal-title":"Molecules"},{"key":"B11","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1007\/s00125-022-05821-3","article-title":"Advanced glycation end-products, cardiac function and heart failure in the general population: the Rotterdam study","volume":"66","author":"Arshi","year":"2023","journal-title":"Diabetologia"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1161\/01.Res.0000103862.26506.3d","article-title":"Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond","volume":"93","author":"Yan","year":"2003","journal-title":"Circ Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s12013-007-0039-0","article-title":"Role of advanced glycation end products in hypertension and atherosclerosis: therapeutic implications","volume":"49","author":"Vasdev","year":"2007","journal-title":"Cell Biochem Biophys"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1401317","DOI":"10.3389\/fendo.2024.1401317","article-title":"Association of the hemoglobin glycation index with cardiovascular and all-cause mortality in individuals with hypertension: findings from NHANES 1999\u20132018","volume":"15","author":"Shangguan","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B15","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1186\/s12933-023-02052-7","article-title":"Advanced glycation end products measured by skin autofluorescence and subclinical cardiovascular disease: the Rotterdam study","volume":"22","author":"Chen","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.biochi.2022.12.020","article-title":"Non-enzymatic glycation of human angiogenin: effects on enzymatic activity and binding to hRI and DNA","volume":"208","author":"Panda","year":"2023","journal-title":"Biochimie"},{"key":"B17","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3390\/foods10020376","article-title":"Glycation of plant proteins via Maillard reaction: reaction chemistry, technofunctional properties, and potential food application","volume":"10","author":"Kutzli","year":"2021","journal-title":"Foods"},{"key":"B18","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/s0014-4800(03)00035-2","article-title":"The role of advanced glycation in the pathogenesis of diabetic retinopathy","volume":"75","author":"Stitt","year":"2003","journal-title":"Exp Mol Pathol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1021\/pr800858h","article-title":"A perspective on the Maillard reaction and the analysis of protein glycation by mass spectrometry: probing the pathogenesis of chronic disease","volume":"8","author":"Zhang","year":"2009","journal-title":"J Proteome Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1093\/gerona\/glq074","article-title":"Does accumulation of advanced glycation end products contribute to the aging phenotype?","volume":"65","author":"Semba","year":"2010","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"B21","doi-asserted-by":"publisher","first-page":"570","DOI":"10.2337\/dc17-1740","article-title":"Advanced glycation end products. oxidation products, and incident cardiovascular events in patients with type 2 diabetes","volume":"41","author":"Koska","year":"2018","journal-title":"Diabetes Care"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.2174\/092986707780830989","article-title":"The road to advanced glycation end products: a mechanistic perspective","volume":"14","author":"Cho","year":"2007","journal-title":"Curr Med Chem"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.2337\/diabetes.52.4.1041","article-title":"Evaluation of autofluorescent property of hemoglobin-advanced glycation end product as a long-term glycemic index of diabetes","volume":"52","author":"Gopalkrishnapillai","year":"2003","journal-title":"Diabetes"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.3390\/s17081798","article-title":"Current status of HbA1c biosensors","volume":"17","author":"Lin","year":"2017","journal-title":"Sensors (Basel)"},{"key":"B25","doi-asserted-by":"publisher","first-page":"9378","DOI":"10.1021\/jf2027395","article-title":"Effect of saccharide structure and size on the degree of substitution and product dispersity of \u03b1-lactalbumin glycated via the Maillard reaction","volume":"59","author":"ter Haar","year":"2011","journal-title":"J Agric Food Chem"},{"key":"B26","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.abb.2015.11.017","article-title":"Oxidative stress and antioxidants: distress or eustress?","volume":"595","author":"Niki","year":"2016","journal-title":"Arch Biochem Biophys"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1172\/jci18127","article-title":"Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells","volume":"112","author":"Du","year":"2003","journal-title":"J Clin Invest"},{"key":"B28","doi-asserted-by":"publisher","first-page":"7489795","DOI":"10.1155\/2020\/7489795","article-title":"Association of glycemic indices (hyperglycemia, glucose variability, and hypoglycemia) with oxidative stress and diabetic complications","volume":"2020","author":"Papachristoforou","year":"2020","journal-title":"J Diabetes Res"},{"key":"B29","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1172\/jci3042","article-title":"The myeloperoxidase system of human phagocytes generates nepsilon-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation","volume":"104","author":"Anderson","year":"1999","journal-title":"J Clin Invest"},{"key":"B30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.atherosclerosis.2007.07.025","article-title":"Receptor for advanced glycation endproducts and atherosclerosis: from basic mechanisms to clinical implications","volume":"196","author":"Basta","year":"2008","journal-title":"Atherosclerosis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"3818196","DOI":"10.1155\/2020\/3818196","article-title":"Advanced glycation end products (AGEs): biochemistry, signaling, analytical methods, and epigenetic effects","volume":"2020","author":"Perrone","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.3305\/nh.2015.31.6.8936","article-title":"Reduction of serum advanced glycation end-products with a low calorie Mediterranean diet","volume":"31","author":"Rodr\u00edguez","year":"2015","journal-title":"Nutr Hosp"},{"key":"B33","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1093\/gerona\/62.4.427","article-title":"Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging","volume":"62","author":"Uribarri","year":"2007","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"B34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5005\/japi-11001-0188","article-title":"Association of POC-based measurement of skin AGEs with serum AGEs as well as AGE biomarkers in individuals with and without glucose intolerance","volume":"71","author":"Regin","year":"2023","journal-title":"J Assoc Physicians India"},{"key":"B35","doi-asserted-by":"publisher","first-page":"105","DOI":"10.17219\/pim\/175544","article-title":"Plasma levels of soluble RAGE, AGEs and AOPPs at the early stage of amyotrophic lateral sclerosis: a preliminary study","volume":"53","author":"Juranek","year":"2023","journal-title":"Polim Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.fertnstert.2009.03.029","article-title":"The measurements of RAGE, VEGF, and AGEs in the plasma and follicular fluid of reproductive women: the influence of aging","volume":"94","author":"Fujii","year":"2010","journal-title":"Fertil Steril"},{"key":"B37","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/s0022-1759(97)00110-5","article-title":"Standardizing the immunological measurement of advanced glycation endproducts using normal human serum","volume":"207","author":"Mitsuhashi","year":"1997","journal-title":"J Immunol Methods"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.2337\/diacare.26.9.2609","article-title":"Impact of metabolic control and serum lipids on the concentration of advanced glycation end products in the serum of children and adolescents with type 1 diabetes, as determined by fluorescence spectroscopy and nepsilon-(carboxymethyl)lysine ELISA","volume":"26","author":"Galler","year":"2003","journal-title":"Diabetes Care"},{"key":"B39","doi-asserted-by":"publisher","first-page":"S110","DOI":"10.1016\/j.dsx.2015.10.004","article-title":"Measurement of urinary advanced glycation end-products (AGEs) using a fluorescence assay for metabolic syndrome-related screening tests","volume":"10","author":"Suehiro","year":"2016","journal-title":"Diabetes Metab Syndr"},{"key":"B40","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1196\/annals.1333.036","article-title":"Simple noninvasive measurement of skin autofluorescence","volume":"1043","author":"Meerwaldt","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"B41","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1089\/dia.2012.0316","article-title":"Clinical and technical factors associated with skin intrinsic fluorescence in subjects with type 1 diabetes from the diabetes control and complications trial\/epidemiology of diabetes interventions and complications study","volume":"15","author":"Cleary","year":"2013","journal-title":"Diabetes Technol Ther"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1007\/s00592-021-01735-5","article-title":"Usefulness of skin advanced glycation end products to predict coronary artery calcium score in patients with type 2 diabetes","volume":"58","author":"Planas","year":"2021","journal-title":"Acta Diabetol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.5551\/jat.30155","article-title":"Association of advanced glycation end products with coronary artery calcification in Japanese subjects with type 2 diabetes as assessed by skin autofluorescence","volume":"23","author":"Hangai","year":"2016","journal-title":"J Atheroscler Thromb"},{"key":"B44","doi-asserted-by":"publisher","first-page":"6309","DOI":"10.1038\/s41598-018-24707-2","article-title":"The association between skin auto-fluorescence of palmoplantar sites and microvascular complications in Asian patients with type 2 diabetes mellitus","volume":"8","author":"Kim","year":"2018","journal-title":"Sci Rep"},{"key":"B45","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1161\/atvbaha.113.302731","article-title":"Skin autofluorescence is associated with 5-year mortality and cardiovascular events in patients with peripheral artery disease","volume":"34","author":"de Vos","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ymeth.2021.12.008","article-title":"Methods to investigate advanced glycation end-product and their application in clinical practice","volume":"203","author":"Corica","year":"2022","journal-title":"Methods"},{"key":"B47","doi-asserted-by":"publisher","first-page":"3480","DOI":"10.1039\/c9bm00184k","article-title":"Glycated collagen\u2014a 3D matrix system to study pathological cell behavior","volume":"7","author":"Dandia","year":"2019","journal-title":"Biomater Sci"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e0193280","DOI":"10.1371\/journal.pone.0193280","article-title":"Advanced glycation end (AGE) product modification of laminin downregulates Kir4.1 in retinal m\u00fcller cells","volume":"13","author":"Thompson","year":"2018","journal-title":"PLoS One"},{"key":"B49","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/00004872-200301000-00002","article-title":"Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes","volume":"21","author":"Aronson","year":"2003","journal-title":"J Hypertens"},{"key":"B50","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3390\/cells13050429","article-title":"Advanced glycation end products upregulate CD40 in human retinal endothelial and M\u00fcller cells: relevance to diabetic retinopathy","volume":"13","author":"Portillo","year":"2024","journal-title":"Cells"},{"key":"B51","doi-asserted-by":"publisher","first-page":"S213","DOI":"10.1111\/j.1447-0594.2010.00603.x","article-title":"Vascular aging: from molecular mechanism to clinical significance","volume":"10","author":"Sawabe","year":"2010","journal-title":"Geriatr Gerontol Int"},{"key":"B52","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.exger.2003.10.003","article-title":"Age-related changes in the glycation of human aortic elastin","volume":"39","author":"Konova","year":"2004","journal-title":"Exp Gerontol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1620\/tjem.180.115","article-title":"Age-related alteration of cross-linking amino acids of elastin in human aorta","volume":"180","author":"Watanabe","year":"1996","journal-title":"Tohoku J Exp Med"},{"key":"B54","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1530\/jme-15-0031","article-title":"Key structural and functional differences between early and advanced glycation products","volume":"56","author":"Paradela-Dobarro","year":"2016","journal-title":"J Mol Endocrinol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"108763","DOI":"10.1016\/j.biopha.2019.108763","article-title":"Inflammatory effects of in vivo glycated albumin from cardiovascular patients","volume":"113","author":"Paradela-Dobarro","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"B56","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1053\/j.ajkd.2024.02.006","article-title":"Glycated albumin and adverse clinical outcomes in patients with CKD: a prospective cohort study","volume":"84","author":"Tang","year":"2024","journal-title":"Am J Kidney Dis"},{"key":"B57","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1161\/circulationaha.115.015415","article-title":"Fructosamine and glycated albumin and the risk of cardiovascular outcomes and death","volume":"132","author":"Selvin","year":"2015","journal-title":"Circulation"},{"key":"B58","doi-asserted-by":"publisher","first-page":"6621568","DOI":"10.1155\/2021\/6621568","article-title":"The neoepitopes on methylglyoxal- (MG-) glycated fibrinogen generate autoimmune response: its role in diabetes, atherosclerosis, and diabetic atherosclerosis subjects","volume":"2021","author":"Rehman","year":"2021","journal-title":"Oxid Med Cell Longev"},{"key":"B59","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1177\/000456329102800613","article-title":"The relative clotting activity of glycated and non-glycated forms of fibrinogen","volume":"28","author":"Robinson","year":"1991","journal-title":"Ann Clin Biochem"},{"key":"B60","doi-asserted-by":"publisher","first-page":"680","DOI":"10.2337\/diab.32.7.680","article-title":"Nonenzymatic glycosylation reduces the susceptibility of fibrin to degradation by plasmin","volume":"32","author":"Brownlee","year":"1983","journal-title":"Diabetes"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1007\/s00125-005-1742-2","article-title":"The influence of type 2 diabetes on fibrin structure and function","volume":"48","author":"Dunn","year":"2005","journal-title":"Diabetologia"},{"key":"B62","doi-asserted-by":"publisher","first-page":"956","DOI":"10.7326\/0003-4819-118-12-199306150-00008","article-title":"Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature","volume":"118","author":"Ernst","year":"1993","journal-title":"Ann Intern Med"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.diabres.2018.04.025","article-title":"Serum fibrinogen predicts diabetic ESRD in patients with type 2 diabetes mellitus","volume":"141","author":"Zhang","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"B64","doi-asserted-by":"publisher","first-page":"e0128881","DOI":"10.1371\/journal.pone.0128881","article-title":"Receptor for advanced glycation end-products signaling interferes with the vascular smooth muscle cell contractile phenotype and function","volume":"10","author":"Simard","year":"2015","journal-title":"PLoS One"},{"key":"B65","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1194\/jlr.D500025-JLR200","article-title":"Ion-trap tandem mass spectrometric analysis of Amadori-glycated phosphatidylethanolamine in human plasma with or without diabetes","volume":"46","author":"Nakagawa","year":"2005","journal-title":"J Lipid Res"},{"key":"B66","doi-asserted-by":"publisher","first-page":"11280","DOI":"10.1039\/c8ra01072b","article-title":"A preliminary study on the formation pathways of glycated phosphatidylethanolamine of food rich in phospholipid during the heat-processing","volume":"8","author":"Lin","year":"2018","journal-title":"RSC Adv"},{"key":"B67","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.freeradbiomed.2019.05.025","article-title":"Analysis of oxidised and glycated aminophospholipids: complete structural characterisation by C30 liquid chromatography-high resolution tandem mass spectrometry","volume":"144","author":"Colombo","year":"2019","journal-title":"Free Radic Biol Med"},{"key":"B68","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/s1388-1981(01)00151-2","article-title":"High glucose and advanced glycation end products induce phospholipid hydrolysis and phospholipid enzyme inhibition in bovine retinal pericytes","volume":"1533","author":"Assero","year":"2001","journal-title":"Biochim Biophys Acta"},{"key":"B69","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1161\/01.Cir.0000135587.92455.0d","article-title":"High levels of dietary advanced glycation end products transform low-density lipoprotein into a potent redox-sensitive mitogen-activated protein kinase stimulant in diabetic patients","volume":"110","author":"Cai","year":"2004","journal-title":"Circulation"},{"key":"B70","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/biomedicines9010018","article-title":"Endothelial dysfunction in diabetes is aggravated by glycated lipoproteins; novel molecular therapies","volume":"9","author":"Toma","year":"2020","journal-title":"Biomedicines"},{"key":"B71","doi-asserted-by":"publisher","first-page":"132257","DOI":"10.1016\/j.ijbiomac.2024.132257","article-title":"Glycated LDL generates reactive species that damage cell components, oxidize hemoglobin and alter surface morphology in human erythrocytes","volume":"269","author":"Wani","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"10828","DOI":"10.1074\/jbc.270.18.10828","article-title":"Identification of the major site of apolipoprotein B modification by advanced glycosylation end products blocking uptake by the low density lipoprotein receptor","volume":"270","author":"Bucala","year":"1995","journal-title":"J Biol Chem"},{"key":"B73","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/s0304-4165(98)00101-9","article-title":"Immunochemical detection of N2-[1-(1-carboxy)ethylguanosine, an advanced glycation end product formed by the reaction of DNA and reducing sugars or L-ascorbic acid in vitro","volume":"1425","author":"Seidel","year":"1998","journal-title":"Biochim Biophys Acta"},{"key":"B74","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1006\/bbrc.1999.1528","article-title":"N(2)-(1-carboxyethyl)deoxyguanosine, a nonenzymatic glycation adduct of DNA, induces single-strand breaks and increases mutation frequencies","volume":"264","author":"Pischetsrieder","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1021\/bi901924b","article-title":"Mutagenic potential of DNA glycation: miscoding by (R)- and (S)-N2-(1-carboxyethyl)-2\u2032-deoxyguanosine","volume":"49","author":"Wuenschell","year":"2010","journal-title":"Biochemistry"},{"key":"B76","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1021\/bi101933p","article-title":"Mutagenesis and repair induced by the DNA advanced glycation end product N2\u20131-(carboxyethyl)-2\u2032-deoxyguanosine in human cells","volume":"50","author":"Tamae","year":"2011","journal-title":"Biochemistry"},{"key":"B77","doi-asserted-by":"publisher","first-page":"100878","DOI":"10.1016\/j.bbrep.2020.100878","article-title":"Acetoacetate enhancement of glucose mediated DNA glycation","volume":"25","author":"Bagherzadeh-Yazdi","year":"2021","journal-title":"Biochem Biophys Rep"},{"key":"B78","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1021\/acs.chemrestox.6b00414","article-title":"DNA advanced glycation end products (DNA-AGEs) are elevated in urine and tissue in an animal model of type 2 diabetes","volume":"30","author":"Jaramillo","year":"2017","journal-title":"Chem Res Toxicol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.2353\/ajpath.2006.051090","article-title":"The metabolic syndrome: a high-risk state for cancer?","volume":"169","author":"Cowey","year":"2006","journal-title":"Am J Pathol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3390\/ijms19020406","article-title":"Inhibition of GLO1 in glioblastoma multiforme increases DNA-AGEs, stimulates RAGE expression, and inhibits brain tumor growth in orthotopic mouse models","volume":"19","author":"Jandial","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1097\/00005072-199712000-00001","article-title":"Aging-associated changes in human brain","volume":"56","author":"Mrak","year":"1997","journal-title":"J Neuropathol Exp Neurol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"H1119","DOI":"10.1152\/ajpheart.00713.2007","article-title":"Lipid mediators of autophagy in stress-induced premature senescence of endothelial cells","volume":"294","author":"Patschan","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"16084","DOI":"10.1038\/s41598-018-33886-x","article-title":"Cardiac troponins may be irreversibly modified by glycation: novel potential mechanisms of cardiac performance modulation","volume":"8","author":"Janssens","year":"2018","journal-title":"Sci Rep"},{"key":"B84","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.3390\/ijms18122602","article-title":"Rapid non-enzymatic glycation of the insulin receptor under hyperglycemic conditions inhibits insulin binding in vitro: implications for insulin resistance","volume":"18","author":"Rhinesmith","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.3390\/cells11081312","article-title":"Advanced glycation end-products (AGEs): formation, chemistry, classification, receptors, and diseases related to AGEs","volume":"11","author":"Twarda-Clapa","year":"2022","journal-title":"Cells"},{"key":"B86","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1096\/fj.08-109033","article-title":"A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10)","volume":"22","author":"Raucci","year":"2008","journal-title":"FASEB J"},{"key":"B87","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.freeradbiomed.2020.12.021","article-title":"Age-dependent accumulation of dicarbonyls and advanced glycation endproducts (AGEs) associates with mitochondrial stress","volume":"164","author":"Akhter","year":"2021","journal-title":"Free Radic Biol Med"},{"key":"B88","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.1007\/s11064-017-2321-x","article-title":"RAGE-specific inhibitor FPS-ZM1 attenuates AGEs-induced neuroinflammation and oxidative stress in rat primary microglia","volume":"42","author":"Shen","year":"2017","journal-title":"Neurochem Res"},{"key":"B89","doi-asserted-by":"publisher","first-page":"E685","DOI":"10.1152\/ajpendo.2001.280.5.E685","article-title":"Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE","volume":"280","author":"Wautier","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B90","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/s0008-6363(97)00233-2","article-title":"AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept","volume":"37","author":"Bierhaus","year":"1998","journal-title":"Cardiovasc Res"},{"key":"B91","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jdiacomp.2012.07.006","article-title":"Advanced glycation end products-induced reactive oxygen species generation is partly through NF-kappa B activation in human aortic endothelial cells","volume":"27","author":"Morita","year":"2013","journal-title":"J Diabetes Complications"},{"key":"B92","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3892\/etm.2013.1125","article-title":"The Rho\/Rho-associated protein kinase inhibitor fasudil in the protection of endothelial cells against advanced glycation end products through the nuclear factor \u03baB pathway","volume":"6","author":"Lu","year":"2013","journal-title":"Exp Ther Med"},{"key":"B93","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jneuroim.2017.02.010","article-title":"Inhibition of AGEs\/RAGE\/rho\/ROCK pathway suppresses non-specific neuroinflammation by regulating BV2 microglial M1\/M2 polarization through the NF-\u03baB pathway","volume":"305","author":"Chen","year":"2017","journal-title":"J Neuroimmunol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"2942830","DOI":"10.1155\/2017\/2942830","article-title":"DJC suppresses advanced glycation end products-induced JAK-STAT signaling and ROS in mesangial cells","volume":"2017","author":"Sun","year":"2017","journal-title":"Evid Based Complement Alternat Med"},{"key":"B95","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.redox.2013.12.016","article-title":"Role of advanced glycation end products in cellular signaling","volume":"2","author":"Ott","year":"2014","journal-title":"Redox Biol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.bbadis.2007.09.001","article-title":"The ligand activity of AGE-proteins to scavenger receptors is dependent on their rate of modification by AGEs","volume":"1772","author":"Nagai","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"B97","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1038\/s41598-019-39202-5","article-title":"Intracellular toxic advanced glycation end-products in cardiomyocytes may cause cardiovascular disease","volume":"9","author":"Takata","year":"2019","journal-title":"Sci Rep"},{"key":"B98","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3390\/biom11030387","article-title":"Intracellular toxic AGEs (TAGE) triggers numerous types of cell damage","volume":"11","author":"Takeuchi","year":"2021","journal-title":"Biomolecules"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.2174\/1389450111009011468","article-title":"Involvement of the toxic AGEs (TAGE)-RAGE system in the pathogenesis of diabetic vascular complications: a novel therapeutic strategy","volume":"11","author":"Takeuchi","year":"2010","journal-title":"Curr Drug Targets"},{"key":"B100","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s10719-018-9831-x","article-title":"Role of AGEs in the progression and regression of atherosclerotic plaques","volume":"35","author":"Wang","year":"2018","journal-title":"Glycoconj J"},{"key":"B101","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1055\/s-0032-1329965","article-title":"Advanced glycation end products-induced vascular calcification is mediated by oxidative stress: functional roles of NAD(P)H-oxidase","volume":"45","author":"Tada","year":"2013","journal-title":"Horm Metab Res"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.3390\/ijms17091567","article-title":"Advanced glycation end-products induce apoptosis of vascular smooth muscle cells: a mechanism for vascular calcification","volume":"17","author":"Koike","year":"2016","journal-title":"Int J Mol Sci"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1172\/jci11951","article-title":"Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE)","volume":"108","author":"Oldfield","year":"2001","journal-title":"J Clin Invest"},{"key":"B104","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1016\/j.diabres.2007.01.030","article-title":"Short-chain aldehyde-derived ligands for RAGE and their actions on endothelial cells","volume":"77","author":"Yamamoto","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"key":"B105","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/1475-2840-12-141","article-title":"The role of profilin-1 in endothelial cell injury induced by advanced glycation end products (AGEs)","volume":"12","author":"Li","year":"2013","journal-title":"Cardiovasc Diabetol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"147030","DOI":"10.1016\/j.gene.2022.147030","article-title":"AGEs induce endothelial cells senescence and endothelial barrier dysfunction via miR-1-3p\/MLCK signaling pathways","volume":"851","author":"Cheng","year":"2023","journal-title":"Gene"},{"key":"B107","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1475-2840-11-46","article-title":"Advanced glycation end products impair the migration, adhesion and secretion potentials of late endothelial progenitor cells","volume":"11","author":"Li","year":"2012","journal-title":"Cardiovasc Diabetol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1475-2840-8-45","article-title":"Association between carotid diameter and the advanced glycation end product N-epsilon-carboxymethyllysine (CML)","volume":"8","author":"Baumann","year":"2009","journal-title":"Cardiovasc Diabetol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ejphar.2014.08.017","article-title":"Contribution of receptor for advanced glycation end products to vasculature-protecting effects of exercise training in aged rats","volume":"741","author":"Gu","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1161\/01.Res.0000065620.39919.20","article-title":"A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes","volume":"92","author":"Candido","year":"2003","journal-title":"Circ Res"},{"key":"B111","doi-asserted-by":"publisher","first-page":"12404","DOI":"10.1016\/S0021-9258(18)42287-9","article-title":"Altered cellular interactions between endothelial cells and nonenzymatically glucosylated laminin\/type IV collagen","volume":"267","author":"Haitoglou","year":"1992","journal-title":"J Biol Chem"},{"key":"B112","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.2337\/diacare.15.12.1835","article-title":"Glycation products and the pathogenesis of diabetic complications","volume":"15","author":"Brownlee","year":"1992","journal-title":"Diabetes Care"},{"key":"B113","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1113\/ep090042","article-title":"AGEs-RAGE axis mediates myocardial fibrosis via activation of cardiac fibroblasts induced by autophagy in heart failure","volume":"107","author":"Liang","year":"2022","journal-title":"Exp Physiol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00424-012-1165-0","article-title":"Advanced glycation end products promote proliferation of cardiac fibroblasts by upregulation of KCa3.1 channels","volume":"464","author":"Zhao","year":"2012","journal-title":"Pflugers Arch"},{"key":"B115","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.3390\/cells10061286","article-title":"Rap1a regulates cardiac fibroblast contraction of 3D diabetic collagen matrices by increased activation of the AGE\/RAGE cascade","volume":"10","author":"Burr","year":"2021","journal-title":"Cells"},{"key":"B116","doi-asserted-by":"publisher","first-page":"e0152376","DOI":"10.1371\/journal.pone.0152376","article-title":"RAGE and TGF-\u03b21 cross-talk regulate extracellular matrix turnover and cytokine synthesis in AGEs exposed fibroblast cells","volume":"11","author":"Serban","year":"2016","journal-title":"PLoS One"},{"key":"B117","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s10020-023-00715-5","article-title":"AGEs promote atherosclerosis by increasing LDL transcytosis across endothelial cells via RAGE\/NF-\u03baB\/caveolin-1 pathway","volume":"29","author":"Shu","year":"2023","journal-title":"Mol Med"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1161\/circresaha.110.217117","article-title":"Activation of protein kinase C isoforms and its impact on diabetic complications","volume":"106","author":"Geraldes","year":"2010","journal-title":"Circ Res"},{"key":"B119","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.3390\/toxins7051722","article-title":"Effect of PKC-\u03b2 signaling pathway on expression of MCP-1 and VCAM-1 in different cell models in response to advanced glycation end products (AGEs)","volume":"7","author":"Rempel","year":"2015","journal-title":"Toxins (Basel"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/j.intimp.2010.09.006","article-title":"Blockade of PKC-beta protects HUVEC from advanced glycation end products induced inflammation","volume":"10","author":"Xu","year":"2010","journal-title":"Int Immunopharmacol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"141","DOI":"10.14744\/AnatolJCardiol.2019.21504","article-title":"Advanced glycation end products facilitate the proliferation and reduce early apoptosis of cardiac microvascular endothelial cells via PKC\u03b2 signaling pathway: insight from diabetic cardiomyopathy","volume":"23","author":"Luan","year":"2020","journal-title":"Anatol J Cardiol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"8607418","DOI":"10.1155\/2020\/8607418","article-title":"Advanced glycation end products induce proliferation and migration of human aortic smooth muscle cells through PI3K\/AKT pathway","volume":"2020","author":"Yuan","year":"2020","journal-title":"Biomed Res Int"},{"key":"B123","doi-asserted-by":"publisher","first-page":"613","DOI":"10.3892\/ijmm.2012.891","article-title":"ERK and Akt signaling pathways are involved in advanced glycation end product-induced autophagy in rat vascular smooth muscle cells","volume":"29","author":"Hu","year":"2012","journal-title":"Int J Mol Med"},{"key":"B124","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/cbf.1736","article-title":"Ghrelin inhibits AGEs-induced apoptosis in human endothelial cells involving ERK1\/2 and PI3K\/Akt pathways","volume":"29","author":"Xiang","year":"2011","journal-title":"Cell Biochem Funct"},{"key":"B125","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.febslet.2009.11.082","article-title":"Advanced glycation end products increase endothelial permeability through the RAGE\/rho signaling pathway","volume":"584","author":"Hirose","year":"2010","journal-title":"FEBS Lett"},{"key":"B126","doi-asserted-by":"publisher","first-page":"9763377","DOI":"10.1155\/2022\/9763377","article-title":"Advanced glycation end products induce atherosclerosis via RAGE\/TLR4 signaling mediated-M1 macrophage polarization-dependent vascular smooth muscle cell phenotypic conversion","volume":"2022","author":"Xing","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2017.06.038","article-title":"Effect of sirolimus on arteriosclerosis induced by advanced glycation end products via inhibition of the ILK\/mTOR pathway in kidney transplantation recipients","volume":"813","author":"Xu","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1111\/j.1523-1755.2004.66004.x","article-title":"AGEs activate mesangial TGF-beta-Smad signaling via an angiotensin II type I receptor interaction","volume":"66","author":"Fukami","year":"2004","journal-title":"Kidney Int"},{"key":"B129","doi-asserted-by":"publisher","first-page":"C850","DOI":"10.1152\/ajpcell.00356.2006","article-title":"Advanced glycation end products induce apoptosis in fibroblasts through activation of ROS, MAP kinases, and the FOXO1 transcription factor","volume":"292","author":"Alikhani","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"key":"B130","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.atherosclerosis.2009.06.007","article-title":"AGEs increased migration and inflammatory responses of adventitial fibroblasts via RAGE, MAPK and NF-kappaB pathways","volume":"208","author":"Liu","year":"2010","journal-title":"Atherosclerosis"},{"key":"B131","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41572-020-0151-7","article-title":"Acute heart failure","volume":"6","author":"Arrigo","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"B132","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1093\/eurjhf\/hfq117","article-title":"Soluble receptor of advanced glycation End products levels are related to ischaemic aetiology and extent of coronary disease in chronic heart failure patients, independent of advanced glycation end products levels: new roles for soluble RAGE","volume":"12","author":"Raposeiras-Roub\u00edn","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"B133","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.semcancer.2017.05.008","article-title":"Hypoxia driven glycation: mechanisms and therapeutic opportunities","volume":"49","author":"Khan","year":"2018","journal-title":"Semin Cancer Biol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1172\/JCI17115","article-title":"Central role of RAGE-dependent neointimal expansion in arterial restenosis","volume":"111","author":"Sakaguchi","year":"2003","journal-title":"J Clin Invest"},{"key":"B135","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1161\/CIRCULATIONAHA.121.055732","article-title":"Extracellular matrix in heart failure: role of ADAMTS5 in proteoglycan remodeling","volume":"144","author":"Barallobre-Barreiro","year":"2021","journal-title":"Circulation"},{"key":"B136","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1161\/CIRCRESAHA.119.311148","article-title":"The extracellular matrix in ischemic and non-ischemic heart failure","volume":"125","author":"Frangogiannis","year":"2019","journal-title":"Circ Res"},{"key":"B137","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1161\/CIRCULATIONAHA.107.728550","article-title":"Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension","volume":"117","author":"van Heerebeek","year":"2008","journal-title":"Circulation"},{"key":"B138","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1161\/CIRCULATIONAHA.111.025270","article-title":"Diabetes mellitus worsens diastolic left ventricular dysfunction in aortic stenosis through altered myocardial structure and cardiomyocyte stiffness","volume":"124","author":"Falc\u00e3o-Pires","year":"2011","journal-title":"Circulation"},{"key":"B139","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00395-017-0646-x","article-title":"Methylglyoxal-derived advanced glycation end products contribute to negative cardiac remodeling and dysfunction post-myocardial infarction","volume":"112","author":"Blackburn","year":"2017","journal-title":"Basic Res Cardiol"},{"key":"B140","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/eurjhf\/hfq168","article-title":"Tissue advanced glycation End products are associated with diastolic function and aerobic exercise capacity in diabetic heart failure patients","volume":"13","author":"Willemsen","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"B141","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1152\/japplphysiol.00146.2019","article-title":"Chronic exercise training prevents coronary artery stiffening in aortic-banded miniswine: role of perivascular adipose-derived advanced glycation end products","volume":"127","author":"Ouyang","year":"2019","journal-title":"J Appl Physiol (1985)"},{"key":"B142","first-page":"1699","article-title":"Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues","volume":"143","author":"Brett","year":"1993","journal-title":"Am J Pathol"},{"key":"B143","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.ejheart.2007.09.009","article-title":"Advanced glycation end\u2013products (AGEs) and heart failure: pathophysiology and clinical implications","volume":"9","author":"Hartog","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"B144","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3390\/cells10030557","article-title":"Rap1a overlaps the AGE\/RAGE signaling cascade to Alter expression of \u03b1-SMA. p-NF-\u03baB, and p-PKC-\u03b6 in cardiac fibroblasts isolated from type: 2, diabetic mice","volume":"10","author":"Burr","year":"2021","journal-title":"Cells"},{"key":"B145","doi-asserted-by":"publisher","first-page":"4480","DOI":"10.3390\/ijms23094480","article-title":"Rap1a activity elevated the impact of endogenous AGEs in diabetic collagen to stimulate increased myofibroblast transition and oxidative stress","volume":"23","author":"Burr","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B146","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/ggi.12499","article-title":"Advanced glycation end-products accelerate the cardiac aging process through the receptor for advanced glycation end-products\/transforming growth factor-\u03b2-Smad signaling pathway in cardiac fibroblasts","volume":"16","author":"Fang","year":"2016","journal-title":"Geriatr Gerontol Int"},{"key":"B147","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1146\/annurev-med-042921-122533","article-title":"Valvular heart disease: new concepts in pathophysiology and therapeutic approaches","volume":"74","author":"Eleid","year":"2023","journal-title":"Annu Rev Med"},{"key":"B148","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1146\/annurev-physiol-012110-142145","article-title":"Heart valve structure and function in development and disease","volume":"73","author":"Hinton","year":"2011","journal-title":"Annu Rev Physiol"},{"key":"B149","doi-asserted-by":"publisher","first-page":"e109","DOI":"10.1161\/CIR.0000000000001254","article-title":"; American Heart Association council on genomic and precision medicine; council on cardiopulmonary, critical care, perioperative and resuscitation; and council on cardiovascular and stroke nursing unraveling the mechanisms of valvular heart disease to identify medical therapy targets: a scientific statement from the American Heart Association","volume":"150","author":"Small","year":"2024","journal-title":"Circulation"},{"key":"B150","doi-asserted-by":"publisher","first-page":"7429","DOI":"10.3390\/ijms24087429","article-title":"Apoptotic cell death in bicuspid-aortic-valve-associated aortopathy","volume":"24","author":"Barnard","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B151","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijcard.2016.06.137","article-title":"Atrial tissue expression of receptor for advanced glycation End-products (RAGE) and atrial fibrosis in patients with mitral valve disease","volume":"220","author":"Yang","year":"2016","journal-title":"Int J Cardiol"},{"key":"B152","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12933-020-01068-7","article-title":"Accumulation of advanced glycation end products (AGEs) is associated with the severity of aortic stenosis in patients with concomitant type 2 diabetes","volume":"19","author":"Kopytek","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"B153","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.atherosclerosis.2009.12.029","article-title":"Circulating soluble receptor for advanced glycation end-product levels are decreased in patients with calcific aortic valve stenosis","volume":"210","author":"Basta","year":"2010","journal-title":"Atherosclerosis"},{"key":"B154","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s00395-012-0306-0","article-title":"Pioglitazone attenuates progression of aortic valve calcification via down-regulating receptor for advanced glycation End products","volume":"107","author":"Li","year":"2012","journal-title":"Basic Res Cardiol"},{"key":"B155","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s10020-024-00833-8","article-title":"Advanced glycation end product-modified low-density lipoprotein promotes pro-osteogenic reprogramming via RAGE\/NF-\u03baB pathway and exaggerates aortic valve calcification in hamsters","volume":"30","author":"Yang","year":"2024","journal-title":"Mol Med"},{"key":"B156","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/sj.ki.5000043","article-title":"Gender-related differences in advanced glycation endproducts, oxidative stress markers and nitric oxide synthases in rats","volume":"69","author":"Wang","year":"2006","journal-title":"Kidney Int"},{"key":"B157","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13293-023-00530-x","article-title":"Coronary artery calcification and aortic valve calcification in patients with kidney failure: a sex-disaggregated study","volume":"14","author":"Ward","year":"2023","journal-title":"Biol Sex Differ"},{"key":"B158","doi-asserted-by":"publisher","first-page":"16006","DOI":"10.1038\/nrdp.2016.6","article-title":"Calcific aortic stenosis","volume":"2","author":"Lindman","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"B159","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.jacc.2018.12.056","article-title":"Detection and prediction of bioprosthetic aortic valve degeneration","volume":"73","author":"Cartlidge","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"B160","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.jacc.2017.07.715","article-title":"Aortic bioprosthetic valve durability: incidence, mechanisms, predictors, and management of surgical and transcatheter valve degeneration","volume":"70","author":"Rodriguez-Gabella","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"B161","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.jacbts.2020.06.008","article-title":"Glycation and serum albumin infiltration contribute to the structural degeneration of bioprosthetic heart valves","volume":"5","author":"Frasca","year":"2020","journal-title":"JACC Basic Transl Sci"},{"key":"B162","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1161\/CIRCULATIONAHA.105.537878","article-title":"Pathophysiology of coronary artery disease","volume":"11","author":"Libby","year":"2005","journal-title":"Circulation"},{"key":"B163","doi-asserted-by":"publisher","first-page":"4985","DOI":"10.1038\/s41467-024-49315-9","article-title":"Smooth muscle NF90 deficiency ameliorates diabetic atherosclerotic calcification in male mice via FBXW7-AGER1-AGEs axis","volume":"15","author":"Xie","year":"2024","journal-title":"Nat Commun"},{"key":"B164","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12944-016-0334-0","article-title":"Advanced glycation end products increase lipids accumulation in macrophages through upregulation of receptor of advanced glycation end products: increasing uptake, esterification and decreasing efflux of cholesterol","volume":"15","author":"Xu","year":"2016","journal-title":"Lipids Health Dis"},{"key":"B165","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.tcm.2018.05.010","article-title":"Oxidized LDL and anti-oxidized LDL antibodies in atherosclerosis\u2014novel insights and future directions in diagnosis and therapy","volume":"29","author":"Hartley","year":"2019","journal-title":"Trends Cardiovasc Med"},{"key":"B166","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.metabol.2022.155162","article-title":"Deacetylation of caveolin-1 by Sirt6 induces autophagy and retards high glucose-stimulated LDL transcytosis and atherosclerosis formation","volume":"131","author":"Zhao","year":"2022","journal-title":"Metab Clin Exp"},{"key":"B167","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.biopha.2017.11.041","article-title":"CML\/CD36 accelerates atherosclerotic progression via inhibiting foam cell migration","volume":"97","author":"Xu","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"B168","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.4239\/wjd.v14.i12.1754","article-title":"Comparative analysis of n\u03b5-carboxymethyl-lysine and inflammatory markers in diabetic and non-diabetic coronary artery disease patients","volume":"14","author":"Shrivastav","year":"2023","journal-title":"World J Diabetes"},{"key":"B169","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N Engl J Med"},{"key":"B170","doi-asserted-by":"publisher","first-page":"18014","DOI":"10.1038\/nrdp.2018.14","article-title":"Hypertension","volume":"4","author":"Oparil","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"B171","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1161\/CIRCRESAHA.121.318061","article-title":"Arterial stiffness and cardiovascular risk in hypertension","volume":"128","author":"Boutouyrie","year":"2021","journal-title":"Circ Res"},{"key":"B172","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.amjhyper.2006.08.009","article-title":"Advanced glycation end-products and arterial stiffness in hypertension","volume":"20","author":"McNulty","year":"2007","journal-title":"Am J Hypertens"},{"key":"B173","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1161\/HYPERTENSIONAHA.120.14515","article-title":"Arterial stiffness in aging: does it have a place in clinical practice?","volume":"77","author":"Mitchell","year":"2021","journal-title":"Hypertension"},{"key":"B174","first-page":"754","article-title":"Arterial stiffness and wave reflections in relation to plasma advanced glycation end products in a Chinese population","volume-title":"Am J Hypertens","author":"Huang","year":"2013"},{"key":"B175","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12933-021-01296-5","article-title":"Advanced glycation end-products, measured as skin autofluorescence, associate with vascular stiffness in diabetic, pre-diabetic and normoglycemic individuals: a cross-sectional study","volume":"20","author":"Birukov","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"B176","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13098-017-0241-1","article-title":"Skin autofluorescence, a non-invasive biomarker for advanced glycation End products, is associated with the metabolic syndrome and its individual components","volume":"9","author":"van Waateringe","year":"2017","journal-title":"Diabetol Metab Syndr"},{"key":"B177","doi-asserted-by":"publisher","first-page":"9418","DOI":"10.1038\/s41598-018-27377-2","article-title":"Uncontrolled hypertension increases risk of all-cause and cardiovascular disease mortality in US adults: the NHANES III linked mortality study","volume":"8","author":"Zhou","year":"2018","journal-title":"Sci Rep"},{"key":"B178","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1210\/clinem\/dgab703","article-title":"High hemoglobin glycation Index is associated with telomere attrition independent of HbA1c, mediated by TNF\u03b1","volume":"107","author":"Lyu","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"B179","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.120.315913","article-title":"Basic mechanisms of diabetic heart disease","volume":"126","author":"Ritchie","year":"2020","journal-title":"Circ Res"},{"key":"B180","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.2337\/dc05-2096","article-title":"Diabetes and advanced glycoxidation end products","volume":"29","author":"Huebschmann","year":"2006","journal-title":"Diabetes Care"},{"key":"B181","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00125-017-4390-4","article-title":"Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease","volume":"61","author":"Jia","year":"2018","journal-title":"Diabetologia"},{"key":"B182","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.apsb.2021.10.005","article-title":"Ferroptosis is essential for diabetic cardiomyopathy and is prevented by sulforaphane via AMPK\/NRF2 pathways","volume":"12","author":"Wang","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"B183","doi-asserted-by":"publisher","first-page":"130478","DOI":"10.1016\/j.ijbiomac.2024.130478","article-title":"Alleviation of albumin glycation-induced diabetic cardiomyopathy by L-arginine: insights into nrf-2 signaling","volume":"264","author":"Thakur","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"B184","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/s41569-022-00692-y","article-title":"The microtubule cytoskeleton in cardiac mechanics and heart failure","volume":"19","author":"Caporizzo","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"B185","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11010-006-9257-9","article-title":"Stable microtubules contribute to cardiac dysfunction in the streptozotocin-induced model of type 1 diabetes in the rat","volume":"294","author":"Shiels","year":"2007","journal-title":"Mol Cell Biochem"},{"key":"B186","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1159\/000364779","article-title":"Effects of advanced glycation end products on calcium handling in cardiomyocytes","volume":"129","author":"Yan","year":"2014","journal-title":"Cardiology"},{"key":"B187","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nri2925","article-title":"Type 2 diabetes as an inflammatory disease","volume":"11","author":"Donath","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"B188","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1038\/s41467-020-15978-3","article-title":"MD2 activation by direct AGE interaction drives inflammatory diabetic cardiomyopathy","volume":"11","author":"Wang","year":"2020","journal-title":"Nat Commun"},{"key":"B189","doi-asserted-by":"publisher","first-page":"5507","DOI":"10.1038\/s44319-024-00271-x","article-title":"Eicosapentaenoic acid induces macrophage mox polarization to prevent diabetic cardiomyopathy","volume":"25","author":"Li","year":"2024","journal-title":"EMBO Rep"},{"key":"B190","doi-asserted-by":"publisher","first-page":"118989","DOI":"10.1016\/j.lfs.2020.118989","article-title":"The effect of miR-471-3p on macrophage polarization in the development of diabetic cardiomyopathy","volume":"268","author":"Liu","year":"2021","journal-title":"Life Sci"},{"key":"B191","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.2337\/db07-1016","article-title":"Specific local cardiovascular changes of n\u025b-(carboxymethyl)Lysine, vascular endothelial growth factor, and Smad2 in the developing embryos coincide with maternal diabetes\u2013induced congenital heart defects","volume":"58","author":"Roest","year":"2009","journal-title":"Diabetes"},{"key":"B192","doi-asserted-by":"publisher","first-page":"4549","DOI":"10.1093\/eurheartj\/ehad477","article-title":"Bicuspid aortic valve: long-term morbidity and mortality","volume":"44","author":"Yang","year":"2023","journal-title":"Eur Heart J"},{"key":"B193","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41569-022-00734-5","article-title":"Transcatheter aortic valve implantation in patients with bicuspid valve morphology: a roadmap towards standardization","volume":"20","author":"Xiong","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"B194","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1161\/ATVBAHA.114.303784","article-title":"Circulating soluble receptor for advanced glycation end product identifies patients with bicuspid aortic valve and associated aortopathies","volume":"34","author":"Branchetti","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B195","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1093\/icvts\/ivab242","article-title":"Circulating soluble receptor of advanced glycation end product is associated with bicuspid aortic aneurysm progression via NF-\u03baB pathway","volume":"34","author":"Jia","year":"2021","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"B196","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.metabol.2015.11.007","article-title":"Atorvastatin prevents advanced glycation end products (AGEs)-induced cardiac fibrosis via activating peroxisome proliferator-activated receptor gamma (PPAR-\u03b3)","volume":"65","author":"Chen","year":"2016","journal-title":"Metab Clin Exp"},{"key":"B197","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.ejphar.2016.07.008","article-title":"Blockade of receptor for advanced glycation end products protects against systolic overload-induced heart failure after transverse aortic constriction in mice","volume":"791","author":"Liu","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"B198","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1212\/WNL.0000000000000364","article-title":"For the Alzheimer\u2019s disease cooperative study clinical trial of an inhibitor of RAGE-a\u03b2 interactions in Alzheimer disease","volume":"82","author":"Galasko","year":"2014","journal-title":"Neurology"},{"key":"B199","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1097\/HJH.0b013e328013e7dd","article-title":"Advanced glycation endproduct crosslink breaker (alagebrium) improves endothelial function in patients with isolated systolic hypertension","volume":"25","author":"Zieman","year":"2007","journal-title":"J Hypertens"},{"key":"B200","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1093\/eurjhf\/hfp207","article-title":"Effects of alagebrium, an advanced glycation end-product breaker, in patients with chronic heart failure: study design and baseline characteristics of the BENEFICIAL trial","volume":"12","author":"Willemsen","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"B201","doi-asserted-by":"publisher","first-page":"4630","DOI":"10.1073\/pnas.95.8.4630","article-title":"Breakers of advanced glycation end products restore large artery properties in experimental diabetes","volume":"95","author":"Wolffenbuttel","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B202","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1073\/pnas.040558497","article-title":"An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness","volume":"97","author":"Asif","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B203","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s10495-020-01602-8","article-title":"Soluble receptor for advanced glycation end-products promotes angiogenesis through activation of STAT3 in myocardial ischemia\/reperfusion injury","volume":"25","author":"Cao","year":"2020","journal-title":"Apoptosis"},{"key":"B204","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.freeradbiomed.2018.10.437","article-title":"Soluble receptor for advance glycation end-products inhibits ischemia\/reperfusion-induced myocardial autophagy via the STAT3 pathway","volume":"130","author":"Dang","year":"2019","journal-title":"Free Radic Biol Med"},{"key":"B205","doi-asserted-by":"publisher","first-page":"11923","DOI":"10.3390\/ijms130911923","article-title":"A soluble receptor for advanced glycation end-products inhibits hypoxia\/reoxygenation-induced apoptosis in rat cardiomyocytes via the mitochondrial pathway","volume":"13","author":"Guo","year":"2012","journal-title":"Int J Mol Sci"},{"key":"B206","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.arabjc.2017.05.011","article-title":"Nanoparticles: properties, applications and toxicities","volume":"12","author":"Khan","year":"2019","journal-title":"Arab J Chem"},{"key":"B207","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ijpharm.2017.05.058","article-title":"Argpyrimidine-tagged rutin-encapsulated biocompatible (ethylene glycol dimers) nanoparticles: application for targeted drug delivery in experimental diabetes (part 2)","volume":"528","author":"Bhattacherjee","year":"2017","journal-title":"Int J Pharm"},{"key":"B208","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1002\/mabi.201500213","article-title":"Enhanced cytoplasmic delivery of RAGE siRNA using bioreducible polyethylenimine-based nanocarriers for myocardial gene therapy","volume":"15","author":"Yang","year":"2015","journal-title":"Macromol Biosci"},{"key":"B209","doi-asserted-by":"publisher","first-page":"3691","DOI":"10.3390\/nu15173691","article-title":"Antihypertensive effects of an optimized aged garlic extract in subjects with grade I hypertension and antihypertensive drug therapy: a randomized, triple-blind controlled trial","volume":"15","author":"Serrano","year":"2023","journal-title":"Nutrients"},{"key":"B210","doi-asserted-by":"publisher","first-page":"107343","DOI":"10.1016\/j.biotechadv.2019.01.010","article-title":"Curcumin, the golden spice in treating cardiovascular diseases","volume":"38","author":"Li","year":"2020","journal-title":"Biotechnol Adv"},{"key":"B211","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.phymed.2018.04.039","article-title":"The potential effect of garlic extract and curcumin nanoparticles against complication accompanied with experimentally induced diabetes in rats","volume":"43","author":"Abdel-Mageid","year":"2018","journal-title":"Phytomedicine"},{"key":"B212","doi-asserted-by":"publisher","first-page":"2403542","DOI":"10.1002\/advs.202403542","article-title":"Engineered macrophage membrane-coated S100A9-siRNA for ameliorating myocardial ischemia-reperfusion injury","volume":"11","author":"Lu","year":"2024","journal-title":"Adv Sci"},{"key":"B213","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1161\/hc3801.097806","article-title":"Improved arterial compliance by a novel advanced glycation end-product crosslink breaker","volume":"104","author":"Kass","year":"2001","journal-title":"Circulation"},{"key":"B214","doi-asserted-by":"publisher","first-page":"101083","DOI":"10.1016\/j.mam.2022.101083","article-title":"Avenues for post-translational protein modification prevention and therapy","volume":"86","author":"Tang","year":"2022","journal-title":"Mol Aspects Med"},{"key":"B215","doi-asserted-by":"publisher","first-page":"285","DOI":"10.5152\/eurasianjmed.2019.18434","article-title":"Alagebrium and complications of diabetes mellitus","volume":"51","author":"Toprak","year":"2019","journal-title":"Eurasian J Med"},{"key":"B216","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s12012-012-9170-2","article-title":"Studies on the cardio protective role of gallic acid against AGE-induced cell proliferation and oxidative stress in H9C2 (2-1) cells","volume":"12","author":"Umadevi","year":"2012","journal-title":"Cardiovasc Toxicol"},{"key":"B217","doi-asserted-by":"publisher","first-page":"133295","DOI":"10.1016\/j.foodchem.2022.133295","article-title":"Inhibitory effects of polyphenols from black chokeberry on advanced glycation end-products (AGEs) formation","volume":"392","author":"Zhao","year":"2022","journal-title":"Food Chem"},{"key":"B218","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.1080\/13880209.2016.1207090","article-title":"Molecular mechanisms of the antiglycative and cardioprotective activities of psidium guajava leaves in the rat diabetic myocardium","volume":"54","author":"Soman","year":"2016","journal-title":"Pharm. Biol"},{"key":"B219","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.2337\/dci23-0040","article-title":"Point-of-care HbA1c in clinical practice: caveats and considerations for optimal use","volume":"47","author":"Sacks","year":"2024","journal-title":"Diabetes Care"},{"key":"B220","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12933-024-02206-1","article-title":"Risk analysis of the association between different hemoglobin glycation index and poor prognosis in critical patients with coronary heart disease-a study based on the MIMIC-IV database","volume":"23","author":"Wei","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B221","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.2337\/dc14-1844","article-title":"The hemoglobin glycation index identifies subpopulations with Harms or benefits from intensive treatment in the ACCORD trial","volume":"38","author":"Hempe","year":"2015","journal-title":"Diabetes Care"},{"key":"B222","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41387-024-00318-x","article-title":"Hemoglobin glycation Index and cardiovascular outcomes in patients with diabetes and coronary artery disease: insights from a large cohort study","volume":"14","author":"Lin","year":"2024","journal-title":"Nutr Diabetes"},{"key":"B223","doi-asserted-by":"publisher","first-page":"2330615","DOI":"10.1080\/07853890.2024.2330615","article-title":"Association between the haemoglobin glycation index (HGI) and clinical outcomes in patients with acute decompensated heart failure","volume":"56","author":"Cheng","year":"2024","journal-title":"Ann Med"},{"key":"B224","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12944-024-02045-9","article-title":"Association of triglyceride glucose-body mass Index and hemoglobin glycation Index with heart failure prevalence in hypertensive populations: a study across different glucose metabolism Status","volume":"23","author":"Wang","year":"2024","journal-title":"Lipids Health Dis"},{"key":"B225","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.numecd.2021.10.018","article-title":"Association between hemoglobin glycation Index and subclinical myocardial injury in the general population free from cardiovascular disease","volume":"32","author":"Wang","year":"2022","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B226","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/1476-511X-13-181","article-title":"Glycated hemoglobin level is significantly associated with the severity of coronary artery disease in non-diabetic adults","volume":"13","author":"Cai","year":"2014","journal-title":"Lipids Health Dis"},{"key":"B227","doi-asserted-by":"publisher","first-page":"1416506","DOI":"10.3389\/fendo.2025.1416506","article-title":"Nonlinear association between glycated hemoglobin levels and mortality in elderly patients with non-diabetic chronic kidney disease: a national health and nutrition examination survey analysis","volume":"16","author":"Huang","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B228","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.biomaterials.2012.09.081","article-title":"Mitigation of diabetes-related complications in implanted collagen and elastin scaffolds using matrix-binding polyphenol","volume":"34","author":"Chow","year":"2013","journal-title":"Biomaterials"},{"key":"B229","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1016\/j.ehj.2004.09.008","article-title":"Markers of inflammation in patients with coronary artery disease are also associated with glycosylated haemoglobin A1c within the normal range","volume":"25","author":"Gustavsson","year":"2004","journal-title":"Eur Heart J"},{"key":"B230","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1161\/01.RES.0000103862.26506.3D","article-title":"Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond","volume":"93","author":"Yan","year":"2003","journal-title":"Circ Res"},{"key":"B231","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","article-title":"Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity","volume":"122","author":"Jia","year":"2018","journal-title":"Circ Res"},{"key":"B232","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1038\/s41401-024-01307-7","article-title":"THBru attenuates diabetic cardiomyopathy by inhibiting RAGE-dependent inflammation","volume":"45","author":"Xu","year":"2024","journal-title":"Acta Pharmacol Sin"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.0000000859","article-title":"Dietary advanced glycation End products and cardiovascular-kidney-metabolic complications","author":"Uribarri","year":"2025","journal-title":"Clin J Am Soc Nephrol"},{"key":"B234","doi-asserted-by":"publisher","first-page":"109990","DOI":"10.1016\/j.diabres.2022.109990","article-title":"Association of hemoglobin glycation index and glycation gap with cardiovascular disease among US adults","volume":"190","author":"Wang","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"B235","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.gene.2016.02.029","article-title":"Genetic analysis of advanced glycation end products in the DHS MIND study","volume":"584","author":"Adams","year":"2016","journal-title":"Gene"},{"key":"B236","doi-asserted-by":"publisher","first-page":"e14261","DOI":"10.1111\/acel.14261","article-title":"Discovery of genomic and transcriptomic pleiotropy between kidney function and soluble receptor for advanced glycation end products using correlated meta-analyses: the long life family study","volume":"23","author":"Feitosa","year":"2024","journal-title":"Aging Cell"},{"key":"B237","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/978-3-319-28383-8_8","article-title":"Impact of non-enzymatic glycation in neurodegenerative diseases: role of natural products in prevention","volume":"12","author":"Ahmad","year":"2016","journal-title":"Adv Neurobiol"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1637252\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T05:30:05Z","timestamp":1756704605000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1637252\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":237,"alternative-id":["10.3389\/fcvm.2025.1637252"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2025.1637252","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,1]]},"article-number":"1637252"}}